EUVIMEDEUVIMED entdecken
Crossref

MiRNAs and tempol therapeutic potential in prostate cancer: a preclinical approach

Isabela Maria Urra Rossetto, Letícia F Alves, Leonardo A Marson, Murilo V Geraldo, Felipe R Santos, Fábio Montico, Valéria H A Cagnon

Journal of Molecular Histology · 2025

DOI: 10.1007/s10735-024-10341-y ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Molecular Histology, 2025. Verfasst von Isabela Maria Urra Rossetto und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Structural and Functional Biology, University of Campinas (UNICAMP), Campinas, SP, Brazil. isabela.urra.rossetto@gmail.com. Hauptthemen laut MEDLINE: Prostatic Neoplasms, MicroRNAs, Cyclic N-Oxides. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo, Conselho Nacional de Desenvolvimento Científico e Tecnológico.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study investigated tempol action on genes and miRNAs related to NFκB pathway in androgen dependent or independent cell lines and in TRAMP model in the early and late-stages of cancer progression. A bioinformatic search was conducted to select the miRNAs to be measured based on the genes of interest from NFκB pathway. The miR-let-7c-5p, miR-26a-5p and miR-155-5p and five target genes (BCL2, BCL2L1, RELA, TNF, PTGS2) were chosen for RT-PCR and gene enrichment analyses. In vitro, PC-3 and LNCaP cells were exposed, respectively, to 1.0 or 2.0 mM of tempol during 48 h. In vivo, five experimental groups were evaluated regarding tempol effects in the early (CT12 and TPL12 groups) and late-stages (CT20, TPL20-I and TLP20-II) of PCa development. TPL groups were treated with 50 mg/kg or 100 mg/kg of tempol. The ventral lobe of the prostate and the plasma was collected. Tempol treatment increased miRs expression in PC-3 and LNCaP. For both cell lines, tempol decreased RELA expression. In TRAMP model, tempol increased miRNA expression in prostate for all treated groups. Tempol upregulated the miRNA expressions related to the NFκB pathway in the prostate tissue and human tumor cell lines. Their increase is mainly linked to increased cell death and delayed CaP aggressivenes. Thus, tempol's capacity for miRNA-mediated gene silencing to decrease tissue proliferation and cell survival processes is part of its tissue mechanics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsMicroRNAsCyclic N-OxidesSpin LabelsMaleHumansAnimalsCell Line, TumorGene Expression Regulation, NeoplasticMiceNF-kappa BDisease Models, Animal

Stichwörter der Autor:innen

NFκBProstate cancerTempolmiRNAs

Substanzen

Spin LabelsMicroRNAsCyclic N-OxidestempolNF-kappa B

Autor:innen und Institutionen

  • Department of Structural and Functional Biology, University of Campinas (UNICAMP), Campinas, SP, Brazil. isabela.urra.rossetto@gmail.com.
  • Department of Structural and Functional Biology, University of Campinas, 255 Monteiro Lobato St, Campinas, SP, 13083-862, Brazil. isabela.urra.rossetto@gmail.com.
  • Department of Structural and Functional Biology, University of Campinas (UNICAMP), Campinas, SP, Brazil.

Förderung

  • Fundação de Amparo à Pesquisa do Estado de São Paulo
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico

Zitieren

APA

Rossetto, I. M. U., Alves, L. F., Marson, L. A., Geraldo, M. V., Santos, F. R., Montico, F., & Cagnon, V. H. A. (2025). MiRNAs and tempol therapeutic potential in prostate cancer: a preclinical approach. Journal of Molecular Histology. https://doi.org/10.1007/s10735-024-10341-y

Vancouver

Rossetto IMU, Alves LF, Marson LA, Geraldo MV, Santos FR, Montico F, et al. MiRNAs and tempol therapeutic potential in prostate cancer: a preclinical approach. Journal of Molecular Histology. 2025. doi:10.1007/s10735-024-10341-y

BibTeX
@article{Rossetto2025,
  author = {Rossetto, Isabela Maria Urra and Alves, Letícia F and Marson, Leonardo A and Geraldo, Murilo V and Santos, Felipe R and Montico, Fábio and Cagnon, Valéria H A},
  title = {MiRNAs and tempol therapeutic potential in prostate cancer: a preclinical approach},
  journal = {Journal of Molecular Histology},
  year = {2025},
  doi = {10.1007/s10735-024-10341-y}
}
Kostenlos starten →